Not a good buy: Value for money of prescription drugs sold on the Internet

Health Policy ◽  
2012 ◽  
Vol 106 (3) ◽  
pp. 241-245 ◽  
Author(s):  
Rosella Levaggi ◽  
Claudio Marcantoni ◽  
Laura Filippucci ◽  
Umberto Gelatti
Keyword(s):  
Prescription Drugs ◽  
The Internet ◽  
Value For Money

USABILITY INTERNET-PHARMACIES SITES

2020 ◽  
pp. 10-14
Author(s):  
Chudnov A.A. ◽  
Umarov S.Z.
Keyword(s):  
Prescription Drugs ◽  
Storage Conditions ◽  
Ease Of Use ◽  
The Internet ◽  
Electronic Prescription ◽  
Anal Ysis ◽  
Modern Development ◽  
Provision Of Services ◽  
The Usa ◽  
Internet Pharmacies

The modern development of information technology provides the opportunity to use them in many areas of life, which also include medicine and pharmacy. The introduction of technologies such as an electronic prescription system, drug labeling, creates the prereq-uisites for the remote provision of services. Recently, legislative changes have legalized the distance trad-ing of OTC drugs. In this regard, soon the supply chain of the drug to the end user may include a mini-mum number of professionals. Thus, in these condi-tions, the role of information that users can receive via the Internet is significantly increasing. Such a term as the "usability" of the site, or its ease of use, appeared back in 1998 and every year is of increasing importance. In relation to online pharmacies, the usa-bility assessment is especially relevant in terms of both general functionality, which is typical for all services selling products via the Internet, and features specific to Internet pharmacies only. On May 8, 2020, an anal-ysis of the "usability" of 20 sites of pharmacy organi-zations was conducted. Some advantages were high-lighted (putting information on the quality of goods (declarations, certificates), warnings, contraindica-tions and storage conditions in a separate block), as well as disadvantages (some clutter of the site with elements, the presence of blank pages and a fuzzy warning about prescription drugs).

A Framework for Privacy Assurance and Ubiquitous Knowledge Discovery in Health 2.0 Data Mashups

Cyber Crime ◽  
2013 ◽  
pp. 263-283 ◽  
Author(s):  
Jun Hu ◽  
Liam Peyton
Keyword(s):  
Health Care ◽  
Knowledge Discovery ◽  
Prescription Drugs ◽  
Personal Information ◽  
Personal Data ◽  
Regulatory Compliance ◽  
The Internet ◽  
Privacy And Security ◽  
Health 2.0 ◽  
Share Data

Knowledge discovery is a critical component in improving health care. Health 2.0 leverages Web 2.0 technologies to integrate and share data from a wide variety of sources on the Internet. There are a number of issues which must be addressed before knowledge discovery can be leveraged effectively and ubiquitously in Health 2.0. Health care data is very sensitive in nature so privacy and security of personal data must be protected. Regulatory compliance must also be addressed if cooperative sharing of data is to be facilitated to ensure that relevant legislation and policies of individual health care organizations are respected. Finally, interoperability and data quality must be addressed in any framework for knowledge discovery on the Internet. In this chapter, we lay out a framework for ubiquitous knowledge discovery in Health 2.0 based on a combination of architecture and process. Emerging Internet standards and specifications for defining a Circle of Trust, in which data is shared but identity and personal information protected, are used to define an enabling architecture for knowledge discovery. Within that context, a step-by-step process for knowledge discovery is defined and illustrated using a scenario related to analyzing the correlation between emergency room visits and adverse effects of prescription drugs. The process we define is arrived at by reviewing an existing standards-based process, CRISP-DM, and extending it to address the new context of Health 2.0.

Government E-Procurement through the Internet

2011 ◽  
pp. 901-905 ◽  
Author(s):  
C. G. Reddick
Keyword(s):  
Public Sector ◽  
Private Sector ◽  
The Internet ◽  
Value For Money ◽  
Radical Process ◽  
The Public ◽  
Electronic Procurement ◽  
Public Sector Organizations ◽  
Conflicting Goals ◽  
Transparency And Accountability

Electronic procurement (e-procurement) is one business-to-government e-commerce venture that can benefit from the Internet. Government e-procurement is different from private sector e-procurement because of concepts such as value for money, transparency and accountability, which may be considered the main benefits for the public sector. Public sector organizations have to meet multiple, often conflicting goals, and they are subject to constraints of a financial, legal, contractual, personnel and institutional nature. In addition, radical process changes from e-procurement can only be achieved with deep changes in bureaucratic practices. These changes cannot normally be achieved without either changes in the law or privatization (Panayiotou, Gayialis, & Tatsiopoulos, 2004).

Medication Access through the Internet: Legal and Safety Considerations for Pharmacists

2005 ◽  
Vol 40 (4) ◽  
pp. 331-335
Author(s):  
Michael A. Veronin
Keyword(s):  
Prescription Drugs ◽  
Drug Regimen ◽  
Legal Issues ◽  
The Internet ◽  
Self Medication ◽  
Potential Health ◽  
Medication Access ◽  
Level Of Activity ◽  
Internet Pharmacies ◽  
Safety Considerations

Today, it is common for patients to order prescription drugs via their home computer through an Internet pharmacy. Because of this, pharmacists may be faced with having to evaluate a patient's drug regimen that may include foreign-made imported drugs obtained through the Internet. This article addresses major issues involving drug importation via this mechanism. Topics discussed include types of Internet pharmacies, patient access to prescription drugs, self-medication, legal issues, and potential health risks. The current level of activity of Internet drug sales has reached record volume and does not appear to be subsiding; pharmacists should be aware of these emerging influences on their practice.

Comparison of Simvastatin Tablets from the US and International Markets Obtained via the Internet

2008 ◽  
Vol 42 (5) ◽  
pp. 613-620 ◽  
Author(s):  
Michael A Veronin ◽  
Nga T Nguyen
Keyword(s):  
Prescription Drugs ◽  
Web Sites ◽  
High Performance ◽  
International Markets ◽  
The Internet ◽  
Content Uniformity ◽  
Innovator Product ◽  
Drug Products ◽  
Weight Variation ◽  
The Us

Background: Convenient access to prescription drugs produced outside the US has been facilitated by the Internet. Of greatest concern to clinicians and policy-makers is product quality and patient safety. The Food and Drug Administration has issued warnings to potential buyers that the safety of drugs purchased through the Internet cannot be guaranteed and may present consumers with a health risk from substandard products. Objective: To determine whether generic simvastatin tablets and capsules obtained via the Internet from international markets are equivalent to the US innovator product regarding major aspects of pharmaceutical quality. Methods: Twenty simvastatin tablets and capsules were obtained for pharmaceutical analysis: 19 generic samples from international Internet pharmacy Web sites and the US innovator product. Tablet samples were tested according to US Pbarmacopeial (USP) guidelines where applicable, using high-performance liquid chromatography, disintegration, dissolution, weight variation, hardness, and assessment of physical characteristics. These tests are often used to detect formulation defects of drug products during the manufacturing process. Results: Several international samples analyzed were not comparable to the US product in one or more aspects of quality assurance testing, and significant variability was found among foreign-made tablets themselves. Five samples failed to meet USP standards for dissolution and 2 for content uniformity. Among all samples, variability was observed in hardness, weight, and physical characterization. Conclusions: Results suggest that manufacturing standards for the international generic drug products compared with the US innovator product are not equivalent with regard to quality attributes. These findings have implications for safety and effectiveness that should be considered by clinicians to potentially safeguard patients who choose to purchase foreign-manufactured drugs via the Internet.

scholarly journals Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"

2020 ◽  
Author(s):  
Marc-André Gagnon
Keyword(s):  
Prescription Drugs ◽  
Access To Medicines ◽  
Academic Community ◽  
Drug Coverage ◽  
Value For Money ◽  
Drug Access ◽  
Canadian Population ◽  
Overwhelming Evidence ◽  
Appropriate Prescribing ◽  
Catastrophic Coverage

Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over.

scholarly journals ADVANTAGES AND RISKS OF ISLAMIC INVESTMENT

2020 ◽  
Vol 20 (2) ◽  
pp. 265-276
Author(s):  
Toto Toto ◽  
Elin Herlina ◽  
Nana Darna
Keyword(s):  
Literature Review ◽  
Profit Sharing ◽  
The Internet ◽  
Minimal Risk ◽  
Value For Money ◽  
Sense Of Security ◽  
The World ◽  
The Difference ◽  
Investment Choices ◽  
Islamic Investment

In the Islamic context, investing is highly recommended so that the future can be guaranteed. Of course, investments made by Muslims must be in accordance with Islamic rules. Investing in economy Islamic concepts will provide a sense of security and comfort for Muslim investors, without fear of deviating from Islamic teachings. As a devout Muslim, of course, investment choices must be appropriate and in accordance with the concept of Islam. The difference between conventional Islamic investment lies in the benefits given. The advantages of Islamic investment are in the form of profit sharing, while the conventional concept is interest. In the teachings of Islam, interest is haram, because it does not recognize value for money. In the view of Islam, money will not developed by itself but must go through productive and ruleful efforts. The purpose of making this paper is to discuss the advantages and risks in Islamic investment. This paper uses a literature review approach that comes from journals, books, the internet, and other sources. The results show that the advantages of Islamic investment are riba-free, minimal risk, Islamic management, halal and promoting social activities. Meanwhile, the risks that may be faced by investors are the risk of losing capital, the risk of uncertainty of return, and the difficulty of selling investment products. From the results, it was found that currently Islamic investment products are favored by non-Muslims alike. The concept of profit sharing is considered more profitable than interest. It can be concluded that Islamic rules can now be accepted by various groups of people in the world.

Consumer Protection: Online Sale of Prescription Drugs to Minors Not Unconscionable

2002 ◽  
Vol 30 (2) ◽  
pp. 315-317
Author(s):  
Charlotte Spears
Keyword(s):  
Supreme Court ◽  
Consumer Protection ◽  
Prescription Drugs ◽  
Attorney General ◽  
Medical Doctor ◽  
District Court ◽  
The Internet ◽  
Online Application ◽  
Online Pharmacy ◽  
Sting Operation

In Stovall v. Confimed.com, the Kansas Supreme Court held that an out-of-state medical doctor who sold a prescription drug to a Kansas minor over the Internet did not commit an unconscionable act under the Kansas Consumer Protection Act (KCPA). The Shawnee Country District Court had enjoined the doctor from prescribing or dispensing prescription medicine within the state of Kansas, and the doctor appealed the injunction to the Kansas Supreme Court. The Supreme Court affirmed the district court's decision to grant injunctive relief, but found no unconscionable conduct under the KCPA.The appellee, Washington physician Dr. Howard J. Levine, sold the sexual enhancement drug Viagra over the Internet through his online pharmacy. Neither the physician nor the online pharmacy was licensed to practice in Kansas. The purchasers were two Kansas residents, one of whom was a minor. Both purchased the drugs in a sting operation conducted by the Kansas Attorney General and received the drugs after completing an online application.

Sign in / Sign up

Export Citation Format

Share Document